Increased CA125 level was only found in about 60% of patients with endometrial cancer, often indicating extrauterine tumor spread, tumor grade, or lymph node metastasis [35].Kakimoto et al. revealed co-expressed CA125 and mesothelin in endometrial tumor tissue [36]. This evidence concerns the gene MSLN and neoplasm.